Clinical Trial Update: Bupivacaine Hydrochloride for Pain Control in Cutaneous Surgery [Phase 1]

View source ↗

Summary

Phase 1 study of bupivacaine hydrochloride for postoperative pain control in cutaneous surgery, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Bupivacaine hydrochloride (bupivacaine hydrochloride)

Snippet

Sponsor: Northwestern University | Conditions: Pain, Postoperative | Phase 1 | Status: ENROLLING_BY_INVITATION